SomaGenics品牌介绍
品牌简介
SomaGenics, Inc. 是一家私营公司，在加利福尼亚州圣克鲁斯设有办事处和实验室。我们专注于开发新的以 RNA 为中心的方法来解决未满足的生命科学研究和医疗需求。我们的核心竞争力包括作为治疗剂的 RNA 分子、药物靶点和生物标志物以及 RNA 分析工具。SomaGenics 在原创研究和出版以及应用开发和商业化方面有着良好的记录。
SomaGenics, Inc. 成立于 1997 年，是 SRI International 的一项技术衍生公司，已从 NIH、NSF、NASA 和 DARPA 等机构筹集了超过 2500 万美元的联邦赠款资金，并拥有令人印象深刻的知识产权组合，涵盖我们的核酸技术用于生命科学研究、治疗和诊断。
SomaGenics, Inc. is a privately held company with offices and laboratories located in Santa Cruz, California. We specialize in developing novel RNA-centered approaches to address unmet life science research and medical needs. Our core competencies include RNA molecules as therapeutic agents, drug targets and biomarkers as well as RNA analysis tools. SomaGenics has a proven track record of original research and publication as well as applied development and commercialization.
Founded in 1997 as a technology spin out from SRI International, SomaGenics, Inc. has raised over $25 million in federal grant funding from agencies such as NIH, NSF, NASA and DARPA and maintains an impressive intellectual property portfolio covering our nucleic acid-based technologies for life science research, therapeutics and diagnostics.
Main product
small RNA detection: qPCR
RNA based therapeutics: sshRNAs
https://www.somagenics.com
联系我们
